HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
Approved
Approval ID
8838d911-0db2-f66e-e053-2995a90acb53
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 6, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2094
Product Classification
G
Generic Name
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 6, 2019
FDA Product Classification
INGREDIENTS (2)
TAZAROTENEActive
Quantity: 0.1 g in 100 g
Code: 81BDR9Y8PS
Classification: ACTIB
HYALURONATE SODIUMActive
Quantity: 0.5 g in 100 g
Code: YSE9PPT4TH
Classification: ACTIB